comparemela.com
Home
Live Updates
Compass Therapeutics Presents Data Demonstrating Elimination of MHC Class I Negative Tumors in In Vivo Models at the 2024 American Association for Cancer Research (AACR) Annual Meeting : comparemela.com
Compass Therapeutics Presents Data Demonstrating Elimination of MHC Class I Negative Tumors in In Vivo Models at the 2024 American Association for Cancer Research (AACR) Annual Meeting
Major Histocompatibility Complex Class I negative tumors are refractory to immune-oncology therapies, including resistance to checkpoint blockers, due to the loss of the fundamental recognition of...
Related Keywords
California ,
United States ,
China ,
Boston ,
Massachusetts ,
San Diego Convention Center ,
San Diego ,
American ,
Thomas Schuetz ,
Danna Gifford ,
Senior Communications ,
American Association For Cancer Research ,
Compass Therapeutics Inc ,
Research Development At Compass ,
Presentations Of The Company ,
Exchange Commission ,
Elpiscience Biopharma Ltd ,
Handok Inc ,
Nasdaq ,
Globenewswire Inc ,
Cancer Research ,
Annual Meeting ,
Diego Convention Center ,
Checkpoint Inhibitor ,
Elpiscience Biopharma ,
Annual Report ,
Quarterly Report ,
comparemela.com © 2020. All Rights Reserved.